GTC Biotherapeutics News
Most Popular GTC Biotherapeutics Story
ALSO NOTED: Novartis sinks$816.5M into Italian vaccine plant; GSK, Astellas take a pass on Theravance's drugs; and much more...
> Novartis is pledging to sink €600 million ($816.5 million) into new and expanded facilities in Italy. Read more...
Latest Headlines
- June 16, 2010
- November 10, 2009
- November 9, 2009
- February 9, 2009
- January 7, 2009
- June 23, 2008
- July 30, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
